A kind of miRNA mark for diagnosing breast cancer and the application of miRNA thereof
A breast cancer and marker technology, applied in the field of biomedicine, can solve the problem of low miRNA expression profile in whole blood
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0050] clinical sample
[0051] In the screening phase, the whole blood of 6 breast cancer patients and 6 age-matched healthy controls collected at Qilu Hospital of Shandong University from February 21, 2012 to July 9, 2012, were detected by miRNA microarray. In the validation phase, from June 27, 2016 to August 30, 2017, Qilu Hospital of Shandong University recruited 68 breast cancer patients and 13 healthy controls. All patients and controls were Han females.
[0052]Fasting venous whole blood (2 ml) was collected and untreated whole blood samples were immediately stored at -80°C or in liquid nitrogen until further analysis. All breast cancer blood samples were collected before surgery or any treatment. Control samples were collected from healthy women with no past or current history of malignancy or inflammation. All participants obtained written informed consent. This study was approved by the Ethics Committee of Qilu Hospital of Shandong University.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com